Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 years ago

Possible Interaction: Arachidonic Acid and Tissue Plasminogen Activator

Research Papers that Mention the Interaction

The phorbol ester TPA significantly increased [3H]arachidonic acid release as well as PGE2 formation in hepatocytes in line with known effects in other cell types.
Journal of cellular physiology  •  2001  |  View Paper
By contrast, a potent PKC activator, TPA , abolished the initial component of the currents and arachidonic acid enhanced this effect.
Biochemical and biophysical research communications  •  1996  |  View Paper
After a 24‐hr incubation with 0.1 μM TPA or 1.0 μM A23187, arachidonic acid elicited significantly more PGE2, synthesis in agonist‐treated cells than it did in control cells in primary culture.
Journal of cellular physiology  •  1992  |  View Paper
The release of arachidonic acid from prelabelled cells was stimulated by TPA and the diacylglycerols even in the presence of an inhibitor of reacylation, indicating an activation of phospholipase A2.
Biological chemistry Hoppe-Seyler  •  1990  |  View Paper
Combined treatment with AA and LHRH or AA plus TPA showed additive effects on P formation.
Likewise, addition of AA partially antagonized the inhibitory effect of 12-O-tetradecanoylphorbol-13-acetate ( TPA ; 10(-9) M) on FSH-induced P production (by 71%).
Endocrinology  •  1989  |  View Paper
In the rat liver cells that had been prelabeled with [3H]arachidonic acid, the release of 6-keto-PGF1 alpha and arachidonic acid also was stimulated by the IL 1, and this release was synergistic in the presence of TPA.
Journal of immunology  •  1985  |  View Paper